Cardiomyopathy-Associated Hospital Admissions Among Methamphetamine Users: Geographical and Social Disparities.

BACKGROUND

Methamphetamine is an emerging drug threat. The disparity in cardiomyopathy-associated hospital admissions among methamphetamine users (CAHMA) over the decade remains unknown.

OBJECTIVES

The purpose of this study was to determine the trends and prevalence of CAHMA by age, sex, race, and geographical region.

METHODS

We used data from 2008 to 2020 from the National Inpatient Sample database. We identified 12,845,919 cardiomyopathy-associated hospital admissions; among them, 222,727 were diagnosed as methamphetamine users. A generalized linear model with binomial link function was used to compute the prevalence ratio and 95% CI. Those who used other substances along with methamphetamine were excluded from the analysis.

RESULTS

CAHMA increased by 231% ( trend <0.001) from 2008 to 2020. CAHMA increased 345% for men ( trend <0.001) and 122% for women ( trend <0.001), 271% for non-Hispanic White ( trend <0.001), 254% for non-Hispanic Black (p trend <0.001), 565% for Hispanic ( trend <0.001), and 645% for non-Hispanic Asian ( trend <0.001) population. CAHMA also increased significantly in the West region (530%) ( trend <0.001) and South region (200%) ( trend <0.001) of the United States. Men, Hispanic population, age groups 26 to 40 and 41 to 64 years, and Western regions showed a significantly higher uptrend than their counterparts ( trend <0.001).

CONCLUSIONS

CAHMA have increased significantly in the United States. Men, Hispanics, non-Hispanic Asian, age groups 41 to 64. and western regions showed a higher proportional increase highlighting gender-based, racial/ethnic, and regional disparities over the study period.